CY2022028I1 - Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας - Google Patents

Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας

Info

Publication number
CY2022028I1
CY2022028I1 CY2022028C CY2022028C CY2022028I1 CY 2022028 I1 CY2022028 I1 CY 2022028I1 CY 2022028 C CY2022028 C CY 2022028C CY 2022028 C CY2022028 C CY 2022028C CY 2022028 I1 CY2022028 I1 CY 2022028I1
Authority
CY
Cyprus
Prior art keywords
transplantation
tumors
antibodies
treatment
autoimmune diseases
Prior art date
Application number
CY2022028C
Other languages
English (en)
Other versions
CY2022028I2 (el
Original Assignee
Viela Bio, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/077916 external-priority patent/WO2008031056A2/en
Application filed by Viela Bio, Inc. filed Critical Viela Bio, Inc.
Publication of CY2022028I1 publication Critical patent/CY2022028I1/el
Publication of CY2022028I2 publication Critical patent/CY2022028I2/el

Links

CY2022028C 2006-09-08 2022-09-13 Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας CY2022028I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84293506P 2006-09-08 2006-09-08
PCT/US2007/077916 WO2008031056A2 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Publications (2)

Publication Number Publication Date
CY2022028I1 true CY2022028I1 (el) 2023-01-05
CY2022028I2 CY2022028I2 (el) 2023-01-05

Family

ID=41104973

Family Applications (1)

Application Number Title Priority Date Filing Date
CY2022028C CY2022028I2 (el) 2006-09-08 2022-09-13 Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας

Country Status (3)

Country Link
CN (1) CN101534859B (el)
CY (1) CY2022028I2 (el)
SI (1) SI2066349T1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016246698B2 (en) * 2015-04-06 2022-06-02 Regeneron Pharmaceuticals, Inc. Humanized T cell mediated immune responses in non-human animals
CN117024588A (zh) * 2016-09-06 2023-11-10 华道(上海)生物医药有限公司 抗cd19抗体在制备白血病治疗药物中的用途
CN106599593B (zh) * 2016-12-22 2019-03-26 贵州源熙生物研发有限公司 一种天然抗癌肽的改造方法
US11634488B2 (en) 2017-07-10 2023-04-25 International—Drug—Development—Biotech Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in combination with anti CD20 antibodies or chemotherapeutics
BR112021020924A2 (pt) * 2019-04-24 2022-04-19 Viela Bio Inc Uso de um anticorpo anti-cd19 para tratar doença autoimune
CN112578117B (zh) * 2021-02-22 2021-05-25 信纳克(北京)生化标志物检测医学研究有限责任公司 抗体组合物及其筛查移植后淋巴细胞增殖性疾病的应用
CN114349863B (zh) * 2022-03-21 2022-07-12 上海优替济生生物医药有限公司 一种抗cd19抗体及其制备方法和用途
CN116516007B (zh) * 2023-04-18 2024-01-19 华中科技大学同济医学院附属协和医院 Cd19表达的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2534639C (en) * 2003-07-31 2013-07-30 Immunomedics, Inc. Anti-cd19 antibodies
AU2006214121B9 (en) * 2005-02-15 2013-02-14 Duke University Anti-CD19 antibodies and uses in oncology

Also Published As

Publication number Publication date
CN101534859B (zh) 2017-06-09
CY2022028I2 (el) 2023-01-05
CN101534859A (zh) 2009-09-16
SI2066349T1 (sl) 2012-08-31

Similar Documents

Publication Publication Date Title
CY2022028I2 (el) Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας
CY2021009I2 (el) Αντισωματα αντι-ρ-σελεκτινης και μεθοδοι χρησης αυτων στην αντιμετωπιση φλεγμονωδων νοσων
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY2020021I1 (el) Αντισωματα και ανοσοσυζευγματα αντι-cd79b και μεθοδοι χρησης
LTPA2017011I1 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
HUS1800025I1 (hu) Örökletes mediterrán láz kezelése anti-IL-1 béta antitestekkel
DK2222706T3 (da) Antibodies against human nkg2d and uses thereof
EP2103628A4 (en) MONOCLONAL ANTIBODY ANTI-CLAUDIN 3, AND TREATMENT AND DIAGNOSIS OF CANCER USING SUCH ANTIBODY
IL197459A0 (en) Humanized proteins, including antibodies and methods for producing the same
EP1998799B8 (en) Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
CY1112277T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
EP1904101A4 (en) ANTI-CD19 ANTIBODY THERAPY FOR TRANSPLANTATION
DK2907827T3 (da) Humaniserede anti-faktor D-antistoffer og anvendelser deraf
DK1844074T3 (da) Humane antistoffer og proteiner
FI20075278A0 (fi) Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
ATE483732T1 (de) Madcam-antikörper
EP1999148B8 (en) Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
SI3002298T1 (sl) Monoklonska protitelesa proti faktorju XI in postopki njihove uporabe
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
EP2185718A4 (en) HUMAN MONOCLONAL ANTIBODIES AND METHOD FOR THEIR MANUFACTURE
ITRM20040105A1 (it) Anticorpo monoclonale antitenascina umana.
ATE518887T1 (de) Anti-igsf4-antikörper und dessen verwendung